Amcinonide NDC 0168-0278

NDC codes

FDA NDC Directory

Product NDC (as listed)0168-0278Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00168-0278Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0168-0278-15	00168027815	1 TUBE in 1 CARTON (0168-0278-15) / 15 g in 1 TUBEMarketed from May 15, 2003
0168-0278-30	00168027830	1 TUBE in 1 CARTON (0168-0278-30) / 30 g in 1 TUBEMarketed from May 15, 2003
0168-0278-60	00168027860	1 TUBE in 1 CARTON (0168-0278-60) / 60 g in 1 TUBEMarketed from May 15, 2003

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amcinonide
Generic name (nonproprietary): amcinonide
Active ingredients: Amcinonide — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: Fougera Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076065
Marketing start: May 15, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 0168-0278_51093468-b64d-4b34-9627-8e6313c8265eSPL ID 51093468-b64d-4b34-9627-8e6313c8265eSPL set ID 8aefa477-ac2c-41c8-a807-d24522aed8f0RxCUI 197327UNII 423W026MA9UPC 0301680278155
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400168027815 followed by a unit qualifier and the quantity

Package 00168-0278-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 27, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)